Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) EPS (Basic) (2016 - 2025)

Conmed (CNMD) has disclosed EPS (Basic) for 11 consecutive years, with $0.84 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, EPS (Basic) rose 58.49% year-over-year to $0.84, compared with a TTM value of $0.33 through Dec 2020, down 67.65%, and an annual FY2025 reading of $1.52, down 64.57% over the prior year.
  • EPS (Basic) was $0.84 for Q4 2020 at Conmed, up from $0.24 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.67 in Q4 2017 and bottomed at -$0.96 in Q2 2020.
  • Average EPS (Basic) over 5 years is $0.27, with a median of $0.24 recorded in 2016.
  • The sharpest move saw EPS (Basic) soared 595.83% in 2017, then crashed 580.0% in 2020.
  • Year by year, EPS (Basic) stood at $0.24 in 2016, then skyrocketed by 595.83% to $1.67 in 2017, then tumbled by 67.07% to $0.55 in 2018, then dropped by 3.64% to $0.53 in 2019, then soared by 58.49% to $0.84 in 2020.
  • Business Quant data shows EPS (Basic) for CNMD at $0.84 in Q4 2020, $0.24 in Q3 2020, and -$0.96 in Q2 2020.